{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:13:48Z","timestamp":1789427628730,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Chi-Mei Medical Center","award":["CMNCKU10009"],"award-info":[{"award-number":["CMNCKU10009"]}]},{"DOI":"10.13039\/501100003711","name":"Ministry of Science and Technology \u2013 Taiwan","doi-asserted-by":"publisher","award":["100-2320-B-006-007-MY3"],"award-info":[{"award-number":["100-2320-B-006-007-MY3"]}],"id":[{"id":"10.13039\/501100003711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004319","name":"Shin Kong Wu Ho-Su Memorial Hospital","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004319","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.antiviral.2014.08.002","type":"journal-article","created":{"date-parts":[[2014,8,21]],"date-time":"2014-08-21T09:51:34Z","timestamp":1408614694000},"page":"158-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Fluoxetine a novel anti-hepatitis C virus agent via ROS-, JNK-, and PPAR\u03b2\/\u03b3-dependent pathways"],"prefix":"10.1016","volume":"110","author":[{"given":"Kung-Chia","family":"Young","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chyi-Huey","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Chen","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Ju","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Yu","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Sheng","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Min","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Wen","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee-Won","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yau-Sheng","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiung-Wen","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2014.08.002_b0005","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.phrs.2003.07.016","article-title":"Studies on the anti-inflammatory effect of fluoxetine in the rat","volume":"49","author":"Abdel-Salam","year":"2004","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.antiviral.2014.08.002_b0010","doi-asserted-by":"crossref","first-page":"605302","DOI":"10.1155\/2012\/605302","article-title":"PPARs and HCV-related hepatocarcinoma: a mitochondrial point of view","volume":"2012","author":"Agriesti","year":"2012","journal-title":"PPAR Res."},{"key":"10.1016\/j.antiviral.2014.08.002_b0015","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1097\/PSY.0b013e3181f883ce","article-title":"Selective serotonin reuptake inhibitor suppression of HIV infectivity and replication","volume":"72","author":"Benton","year":"2010","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.antiviral.2014.08.002_b0020","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1440-1819.2009.02004.x","article-title":"Total antioxidant capacity and total oxidant status in patients with major depression: impact of antidepressant treatment","volume":"63","author":"Cumurcu","year":"2009","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.antiviral.2014.08.002_b0025","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jhep.2005.11.046","article-title":"Depression, anemia and health-related quality of life in chronic hepatitis C","volume":"44","author":"Dan","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2014.08.002_b0030","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1186\/1743-422X-8-351","article-title":"Mechanism of HCV\u2019s resistance to IFN-alpha in cell culture involves expression of functional IFN-alpha receptor 1","volume":"8","author":"Datta","year":"2011","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2014.08.002_b0035","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1038\/sj.onc.1203481","article-title":"Serine phosphorylation of STATs","volume":"19","author":"Decker","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.antiviral.2014.08.002_b0040","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.3748\/wjg.v11.i14.2157","article-title":"Effect of hepatitis C virus nonstructural protein NS3 on proliferation and MAPK phosphorylation of normal hepatocyte line","volume":"11","author":"Feng","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.antiviral.2014.08.002_b0045","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0092-8674(95)90193-0","article-title":"15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma","author":"Forman","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2014.08.002_b0050","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1111\/j.1471-4159.2005.03149.x","article-title":"Chronic fluoxetine administration inhibits extracellular signal-regulated kinase 1\/2 phosphorylation in rat brain","volume":"93","author":"Fumagalli","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.antiviral.2014.08.002_b0055","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.genhosppsych.2010.03.001","article-title":"Can antidepressants prevent interferon-alpha-induced depression? A review of the literature","volume":"32","author":"Galvao-de Almeida","year":"2010","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.antiviral.2014.08.002_b0060","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1378\/chest.107.6.1763","article-title":"Fluoxetine hydrochloride (Prozac)-induced pulmonary disease","volume":"107","author":"Gonzalez-Rothi","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.antiviral.2014.08.002_b0065","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1099\/vir.0.016899-0","article-title":"Hepatitis C virus RNA replication is regulated by Ras-Erk signalling","volume":"91","author":"Gretton","year":"2010","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2014.08.002_b0070","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2147\/nedt.2006.2.3.355","article-title":"Interferon-induced depressive illness in hep C patients responds to SSRI antidepressant treatments","volume":"2","author":"Gupta","year":"2006","journal-title":"Neuropsychiatry Dis. Treat."},{"key":"10.1016\/j.antiviral.2014.08.002_b0075","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.neulet.2005.12.022","article-title":"Fluoxetine increases the nitric oxide production via nuclear factor kappa B-mediated pathway in BV2 murine microglial cells","volume":"397","author":"Ha","year":"2006","journal-title":"Neurosci. Lett."},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2014.08.002_b0080","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1478-3231.2011.02716.x","article-title":"Future treatment of chronic hepatitis C with direct acting antivirals: is resistance important?","volume":"32","author":"Halfon","year":"2012","journal-title":"Liver Int."},{"key":"10.1016\/j.antiviral.2014.08.002_b0085","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.virol.2005.01.008","article-title":"Activation of c-Jun NH2-terminal kinase (JNK) signaling pathway is essential for the stimulation of hepatitis C virus (HCV) non-structural protein 3 (NS3)-mediated cell growth","volume":"333","author":"Hassan","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2014.08.002_b0090","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00535-005-1740-7","article-title":"Antiviral therapy for chronic hepatitis C: past, present, and future","volume":"41","author":"Hayashi","year":"2006","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.antiviral.2014.08.002_b0095","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.antiviral.2007.11.008","article-title":"A screening method for identifying disruptions in interferon signaling reveals HCV NS3\/4a disrupts Stat-1 phosphorylation","volume":"77","author":"Helbig","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.08.002_b0100","doi-asserted-by":"crossref","first-page":"22733","DOI":"10.1074\/jbc.R110.133017","article-title":"Hepatitis C virus: assembly and release of virus particles","volume":"285","author":"Jones","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2014.08.002_b0105","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbrc.2009.05.129","article-title":"Regulation of hepatitis C virus replication by the core protein through its interaction with viral RNA polymerase","volume":"386","author":"Kang","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2014.08.002_b0110","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1007\/s00018-010-0351-5","article-title":"Endocytosis of hepatitis C virus non-enveloped capsid-like particles induces MAPK-ERK1\/2 signaling events","volume":"67","author":"Katsarou","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.antiviral.2014.08.002_b0115","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1128\/JVI.00954-12","article-title":"Contrasting roles of mitogen-activated protein kinases in cellular entry and replication of hepatitis C virus: MKNK1 facilitates cell entry","volume":"87","author":"Kim","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.08.002_b0120","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1365-2893.2005.00554.x","article-title":"Prophylactic SSRI during interferon alpha re-therapy in patients with chronic hepatitis C and a history of interferon-induced depression","volume":"12","author":"Kraus","year":"2005","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.antiviral.2014.08.002_b0125","doi-asserted-by":"crossref","first-page":"8581","DOI":"10.1128\/JVI.00533-12","article-title":"Hepatitis C virus NS5A disrupts STAT1 phosphorylation and suppresses type I interferon signaling","volume":"86","author":"Kumthip","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.08.002_b0130","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3858\/emm.2012.44.10.066","article-title":"Peroxisome proliferator-activated receptor delta agonist attenuates hepatic steatosis by anti-inflammatory mechanism","volume":"44","author":"Lee","year":"2012","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.antiviral.2014.08.002_b0135","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1042\/CS20100387","article-title":"Enhanced expression of pro-inflammatory mediators and liver X-receptor-regulated lipogenic genes in non-alcoholic fatty liver disease and hepatitis C","volume":"120","author":"Lima-Cabello","year":"2011","journal-title":"Clin. Sci."},{"key":"10.1016\/j.antiviral.2014.08.002_b0140","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.1128\/JVI.68.8.5063-5073.1994","article-title":"Processing in the hepatitis C virus E2-NS2 region: identification of p7 and two distinct E2-specific products with different C termini","volume":"68","author":"Lin","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.08.002_b0145","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1099\/vir.0.80204-0","article-title":"Hepatitis C virus NS5A: tales of a promiscuous protein","volume":"85","author":"Macdonald","year":"2004","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2014.08.002_b0150","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2165\/11533280-000000000-00000","article-title":"The association between conventional antidepressants and the metabolic syndrome: a review of the evidence and clinical implications","volume":"24","author":"McIntyre","year":"2010","journal-title":"CNS Drugs"},{"key":"10.1016\/j.antiviral.2014.08.002_b0155","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1159\/000205264","article-title":"Predictive value of the phosphorylation of signal transducers and activators of transcription in the outcome of interferon therapy for chronic hepatitis C","volume":"51","author":"Miyaaki","year":"2008","journal-title":"Intervirology"},{"key":"10.1016\/j.antiviral.2014.08.002_b0160","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/ncb1631","article-title":"The lipid droplet is an important organelle for hepatitis C virus production","volume":"9","author":"Miyanari","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.antiviral.2014.08.002_b0165","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2174\/1574886311308030011","article-title":"Liver injury associated with antidepressants","volume":"8","author":"Park","year":"2013","journal-title":"Curr Drug Saf."},{"key":"10.1016\/j.antiviral.2014.08.002_b0170","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1099\/vir.0.020644-0","article-title":"Hepatitis C virus core protein genotype 3a increases SOCS-7 expression through PPAR-{gamma} in Huh-7 cells","volume":"91","author":"Pazienza","year":"2010","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2014.08.002_b0175","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1128\/AAC.37.3.540","article-title":"Strategic design and three-dimensional analysis of antiviral drug combinations","volume":"37","author":"Prichard","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2014.08.002_b0180","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0166-3542(90)90001-N","article-title":"A three-dimensional model to analyze drug\u2013drug interactions","volume":"14","author":"Prichard","year":"1990","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.08.002_b0185","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1177\/153537020122600903","article-title":"Drug-induced phospholipidosis: are there functional consequences?","volume":"226","author":"Reasor","year":"2001","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.antiviral.2014.08.002_b0190","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1465-9921-8-35","article-title":"Anti-inflammatory properties of desipramine and fluoxetine","volume":"8","author":"Roumestan","year":"2007","journal-title":"Respir. Res."},{"key":"10.1016\/j.antiviral.2014.08.002_b0195","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/JCP.0b013e3182a47397","article-title":"Longitudinal effects of selective serotonin reuptake inhibitor therapy and cytokine-related depression on hepatitis C viral logs during antiviral therapy","volume":"34","author":"Sims","year":"2014","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.antiviral.2014.08.002_b0200","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1177\/070674370905400906","article-title":"Managing depression during hepatitis C treatment","volume":"54","author":"Sockalingam","year":"2009","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.antiviral.2014.08.002_b0205","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1136\/gutjnl-2011-301798","article-title":"Very low-density lipoprotein\/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III","volume":"62","author":"Sun","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.antiviral.2014.08.002_b0210","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.tem.2009.07.005","article-title":"Hepatitis C virus hijacks host lipid metabolism","volume":"21","author":"Syed","year":"2010","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.antiviral.2014.08.002_b0215","first-page":"683","article-title":"PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice","volume":"118","author":"Tanaka","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.antiviral.2014.08.002_b0220","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1002\/jcp.22994","article-title":"Glycogen synthase kinase-3beta is critical for interferon-alpha-induced serotonin uptake in human Jurkat T cells","volume":"227","author":"Tsao","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.antiviral.2014.08.002_b0225","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.bbi.2011.12.011","article-title":"A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia","volume":"26","author":"Tynan","year":"2012","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.antiviral.2014.08.002_b0230","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1128\/AAC.02084-12","article-title":"Selective serotonin reuptake inhibitor fluoxetine inhibits replication of human enteroviruses B and D by targeting viral protein 2C","volume":"57","author":"Ulferts","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2014.08.002_b0235","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1128\/JVI.00688-11","article-title":"Activation of the Ras\/Raf\/MEK pathway facilitates hepatitis C virus replication via attenuation of the interferon-JAK-STAT pathway","volume":"86","author":"Zhang","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.08.002_b0240","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.1128\/AAC.00983-12","article-title":"Fluoxetine is a potent inhibitor of coxsackievirus replication","volume":"56","author":"Zuo","year":"2012","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214002393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214002393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,23]],"date-time":"2020-08-23T14:58:03Z","timestamp":1598194683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354214002393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":48,"alternative-id":["S0166354214002393"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.08.002","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluoxetine a novel anti-hepatitis C virus agent via ROS-, JNK-, and PPAR\u03b2\/\u03b3-dependent pathways","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}